Pharma stocks just got a new risk factorand it's not a new drug trial. President Trump is preparing to slap tariffs on ...

For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...

Partnership aims to replenish more than 300,000 cubic metres of water and positively impact over 100,000 people in Pakistan and India ...

GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing) and secondary (finished product creation) locations. Therefore, the first challenge was ...

FTSE 100 p harma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...

WWF, the world’s leading independent conservation organisation, and GSK, a global biopharma company, have announced a major multi-million-pound partnership running to 2030.

Companies like Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE), and GSK (NYSE:GSK ... Analysts warn the tariffs could rattle global supply chains, trigger short-term drug shortages, and erode profit ...

The early results have included faster drug discovery, highly optimized supply chains, and greater awareness of consumer demand. For GSK’s Ramakrishnan, who has served as CDTO since 2021 ...

Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' ...

London’s FTSE 100 was down 1.3% at 8,494.83 in afternoon trade on Thursday as investors mulled Trump’s bombshell tariff ...